Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009
Dispatch

Mycobacterium bolletii Respiratory Infections

Toïdi Adékambi1 and Michel DrancourtComments to Author 
Author affiliations: Université de la Méditerranée, Marseille, France

Main Article

Table

Antimicrobial drug susceptibility test results (MICs) for Mycobacterium bolletii isolates*

Antimicrobial agent Patient 1 Patient 2 Patient 3 Patient 4
Penicillin >32 >32 >32 >32
Amoxicillin >256 >256 >256 >256
Amoxicillin clavulanate (disc 20 µg + 10 µg) >4 >4 >4 >4
Cefoxitin >256 >256 >256 >256
Ceftriaxone >256 >256 >256 >256
Cefotaxime >256 >256 >256 >256
Imipenen >32 >32 >32 >32
Doxycycline >32 >32 >32 >32
Minocycline >256 >256 >256 >256
Clarithromycin >256 >256 >256 >256
Erythromycin >256 >256 >256 >256
Azithromycin >256 >256 >256 >256
Amikacin 32 48 32 48
Tobramycin >32 >32 >32 >32
Ciprofloxacin >32 >32 >32 >32
Ofloxacin >32 >32 >32 >32
Sparfloxacin >32 >32 >32 >32
Rifampicin >32 >32 >32 >32
Metronidazole >256 >256 >256 >256
Teicoplanine >256 >256 >256 >256
Vancomycin >256 >256 >256 >256
Trimethoprim-sulfamethoxazole >32 >32 >32 >32

*Values given in μg/mL.

Main Article

1Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external